---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-025653"
form_type: "8-K"
ticker: "NRC"
cik: "0000070487"
company_name: "NRC HEALTH"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T10:17:17.161821+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# National Research Corp Q3 revenue flat at $37.7M; EPS down to $0.33 from $0.38

## Summary
- Revenue $37.7M vs $37.8M prior year; net income $8.3M vs $9.7M; diluted EPS $0.33 vs $0.38.
- CFO cited investments in innovation, marketing, and associate retention as margin headwinds.
- Canadian operations phase-out and non-core decline offset core growth.
- Paid $5.9M in dividends and $3.6M for share repurchases in Q3.

## SEC filing metadata
- accession: 0001437749-22-025653
- form_type: 8-K
- ticker: NRC
- cik: 0000070487
- company_name: NRC HEALTH
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70487/000143774922025653/0001437749-22-025653-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70487/000143774922025653/nrc20221102_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-025653
- JSON: https://secwatch.observer/filing/0001437749-22-025653.json
- Plain text: https://secwatch.observer/filing/0001437749-22-025653.txt

## Key facts
- Earnings Releases
  NRC HEALTH reported third quarter ended September 30, 2022 results: revenue $37.7 million, net income $8.3 million, EPS $0.33.
  - Period: third quarter ended September 30, 2022
  - Revenue: $37.7 million
  - Net income: $8.3 million
  - EPS: $0.33
  - Result: reported results
  source text: Revenue for the third quarter ended September 30, 2022, was $37.7 million, compared to $37.8 million for the same quarter in 2021. Net income for the quarter ended September 30, 2022, was $8.3 million, compared to $9.7 million for the quarter ended September 30, 2021. Diluted earnings per share decreased to $0.33 for the quarter ended September 30, 2022, from diluted earnings per share of $0.38 for the quarter ended September 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/70487/000143774922025653/0001437749-22-025653-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.